Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections—A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug

Background: Poor outcomes in severe and resistant infections, together with the economic struggles of companies active in the field of anti-infective development, call for new solutions and front runners with novel approaches. Among “non-traditional” approaches, blocking virulence could be a game ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Azeredo da Silveira, Samareh, Shorr, Andrew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Concept Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168140/
https://www.ncbi.nlm.nih.gov/pubmed/32098274
http://dx.doi.org/10.3390/antibiotics9020094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168140/
https://www.ncbi.nlm.nih.gov/pubmed/32098274
http://dx.doi.org/10.3390/antibiotics9020094

Ejemplares similares